Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in hepatic encephalopathy.

Victoria Liere1, Gurkarminder Sandhu2, Sharon DeMorrow1,3

  • 1Department of Medical Physiology, College of Medicine, Texas A&M Health Science Center, Temple, TX, USA.

F1000Research
|October 14, 2017
PubMed
Summary

This review summarizes recent advances in understanding the pathogenesis, diagnosis, and treatment of hepatic encephalopathy (HE), a neurological condition linked to liver injury. It highlights key research from the past three years, focusing on ammonia, neurosteroids, and neuroinflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central Administration of Recombinant IGF1 Is Neuroprotective in a Rodent Model of Acute Liver Failure.

International journal of molecular sciences·2026
Same author

Biochemical and Physiological Effects of Galanin in Health and Disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Ataxia-telangiectasia mutated activation mediates transforming growth factor beta signaling in acetaminophen-induced liver injury in mice.

Physiological reports·2025
Same author

The Role of Neuroinflammation in the Pathogenesis of Hepatic Encephalopathy.

Journal of immunology research·2025
Same author

CD47 signaling induces hepatic cell death and microglia activation during hepatic encephalopathy.

Metabolic brain disease·2024
Same author

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.

Cells·2021

Area of Science:

  • Hepatology
  • Neurology
  • Gastroenterology

Background:

  • Hepatic encephalopathy (HE) encompasses neurological changes seen in acute liver failure or chronic liver injury.
  • Key factors like elevated brain ammonia, altered neurosteroid levels, and neuroinflammation are implicated in HE pathogenesis.
  • Despite identified factors, the precise pathogenic mechanisms of HE remain incompletely understood.

Purpose of the Study:

  • To provide a concise overview of current understanding regarding the pathogenesis of hepatic encephalopathy.
  • To summarize recent clinical and basic research advancements in HE.
  • To cover recent progress in the understanding, diagnosis, and potential treatments for hepatic encephalopathy.

Main Methods:

  • A literature search was performed on the PubMed database in May 2017.
Keywords:
Hepatic encephalopathyacute liver failurechronic liver injuryneuroinflammationpathogenesis

Related Experiment Videos

  • The search keyword used was "hepatic encephalopathy".
  • Selected articles were limited to research published between May 2014 and May 2017.

    • Main Results:

    • Recent research has yielded significant advances in understanding HE.
    • Progress has been made in diagnostic methods and therapeutic strategies for HE.
    • The review consolidates findings on ammonia, neurosteroids, and neuroinflammation in HE.

    Conclusions:

    • Recent research has significantly advanced the understanding of hepatic encephalopathy.
    • New insights offer potential for improved diagnosis and treatment of HE.
    • Continued research is crucial for fully elucidating HE pathogenesis and developing effective therapies.